FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:IL17RC-TTLL3

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: IL17RC-TTLL3
FusionPDB ID: 39448
FusionGDB2.0 ID: 39448
HgeneTgene
Gene symbol

IL17RC

TTLL3

Gene ID

84818

26140

Gene nameinterleukin 17 receptor Ctubulin tyrosine ligase like 3
SynonymsCANDF9|IL17-RL|IL17RLHOTTL
Cytomap

3p25.3|3p25.3-p24.1

3p25.3

Type of geneprotein-codingprotein-coding
Descriptioninterleukin-17 receptor CIL-17 receptor CIL-17RLIL17F receptorIL17Rhominterleukin-17 receptor homologinterleukin-17 receptor-like proteinzcytoR14tubulin monoglycylase TTLL3tubulin tyrosine ligase-like family, member 3tubulin--tyrosine ligase-like protein 3
Modification date2020032020200313
UniProtAcc

Q8NAC3

Main function of 5'-partner protein: FUNCTION: Receptor for IL17A and IL17F, major effector cytokines of innate and adaptive immune system involved in antimicrobial host defense and maintenance of tissue integrity (By similarity). Receptor for IL17A and IL17F, major effector cytokines of innate and adaptive immune system involved in antimicrobial host defense and maintenance of tissue integrity. Receptor for IL17A and IL17F homodimers as part of a heterodimeric complex with IL17RA (PubMed:16785495). Receptor for the heterodimer formed by IL17A and IL17B as part of a heterodimeric complex with IL17RA (PubMed:18684971). Has also been shown to be the cognate receptor for IL17F and to bind IL17A with high affinity without the need for IL17RA (PubMed:17911633). Upon binding of IL17F homodimer triggers downstream activation of TRAF6 and NF-kappa-B signaling pathway (PubMed:16785495, PubMed:32187518). Induces transcriptional activation of IL33, a potent cytokine that stimulates group 2 innate lymphoid cells and adaptive T-helper 2 cells involved in pulmonary allergic response to fungi (By similarity). Promotes sympathetic innervation of peripheral organs by coordinating the communication between gamma-delta T cells and parenchymal cells. Stimulates sympathetic innervation of thermogenic adipose tissue by driving TGFB1 expression (By similarity). Binding of IL17A-IL17F to IL17RA-IL17RC heterodimeric receptor complex triggers homotypic interaction of IL17RA and IL17RC chains with TRAF3IP2 adapter through SEFIR domains. This leads to downstream TRAF6-mediated activation of NF-kappa-B and MAPkinase pathways ultimately resulting in transcriptional activation of cytokines, chemokines, antimicrobial peptides and matrix metalloproteinases, with potential strong immune inflammation (PubMed:18684971, PubMed:17911633). Primarily induces neutrophil activation and recruitment at infection and inflammatory sites (By similarity). Stimulates the production of antimicrobial beta-defensins DEFB1, DEFB103A, and DEFB104A by mucosal epithelial cells, limiting the entry of microbes through the epithelial barriers (By similarity). {ECO:0000250|UniProtKB:Q8K4C2, ECO:0000269|PubMed:16785495, ECO:0000269|PubMed:17911633, ECO:0000269|PubMed:18684971, ECO:0000269|PubMed:32187518}.; FUNCTION: [Isoform 5]: Receptor for both IL17A and IL17F. {ECO:0000269|PubMed:16785495}.; FUNCTION: [Isoform 6]: Does not bind IL17A or IL17F. {ECO:0000269|PubMed:16785495}.; FUNCTION: [Isoform 7]: Does not bind IL17A or IL17F. {ECO:0000269|PubMed:16785495}.; FUNCTION: [Isoform 8]: Receptor for both IL17A and IL17F. {ECO:0000269|PubMed:16785495}.
.
Ensembl transtripts involved in fusion geneENST idsENST00000498214, ENST00000295981, 
ENST00000383812, ENST00000403601, 
ENST00000413608, ENST00000416074, 
ENST00000455057, 
ENST00000426895, 
ENST00000547186, ENST00000383827, 
ENST00000397241, ENST00000427853, 
ENST00000430793, ENST00000455274, 
ENST00000466245, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score1 X 2 X 2=47 X 7 X 6=294
# samples 28
** MAII scorelog2(2/4*10)=2.32192809488736log2(8/294*10)=-1.877744249949
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: IL17RC [Title/Abstract] AND TTLL3 [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: IL17RC [Title/Abstract] AND TTLL3 [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)IL17RC(9970314)-TTLL3(9857758), # samples:2
Anticipated loss of major functional domain due to fusion event.IL17RC-TTLL3 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
IL17RC-TTLL3 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
IL17RC-TTLL3 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
IL17RC-TTLL3 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
TgeneTTLL3

GO:0018094

protein polyglycylation

19524510



check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr3:9970314/chr3:9857758)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across IL17RC (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across TTLL3 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000383812IL17RCchr39974387+ENST00000426895TTLL3chr39860506+3569168024235681109
ENST00000383812IL17RCchr39974387+ENST00000547186TTLL3chr39860506+4433168024235681108
ENST00000295981IL17RCchr39974387+ENST00000426895TTLL3chr39860506+3803191421838021195
ENST00000295981IL17RCchr39974387+ENST00000547186TTLL3chr39860506+4667191421838021194
ENST00000403601IL17RCchr39974387+ENST00000426895TTLL3chr39860506+3569168019735681124
ENST00000403601IL17RCchr39974387+ENST00000547186TTLL3chr39860506+4433168019735681123
ENST00000416074IL17RCchr39974387+ENST00000426895TTLL3chr39860506+332914404223328969
ENST00000416074IL17RCchr39974387+ENST00000547186TTLL3chr39860506+419314404223328968
ENST00000455057IL17RCchr39974387+ENST00000426895TTLL3chr39860506+3429154015334281091
ENST00000455057IL17RCchr39974387+ENST00000547186TTLL3chr39860506+4293154015334281091
ENST00000413608IL17RCchr39974387+ENST00000426895TTLL3chr39860506+33721483033711123
ENST00000413608IL17RCchr39974387+ENST00000547186TTLL3chr39860506+42361483033711123

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000383812ENST00000426895IL17RCchr39974387+TTLL3chr39860506+0.004883130.99511683
ENST00000383812ENST00000547186IL17RCchr39974387+TTLL3chr39860506+0.0031421570.9968579
ENST00000295981ENST00000426895IL17RCchr39974387+TTLL3chr39860506+0.0061602750.9938398
ENST00000295981ENST00000547186IL17RCchr39974387+TTLL3chr39860506+0.0045559930.99544406
ENST00000403601ENST00000426895IL17RCchr39974387+TTLL3chr39860506+0.0063347990.9936652
ENST00000403601ENST00000547186IL17RCchr39974387+TTLL3chr39860506+0.0043651440.99563485
ENST00000416074ENST00000426895IL17RCchr39974387+TTLL3chr39860506+0.0045970480.99540293
ENST00000416074ENST00000547186IL17RCchr39974387+TTLL3chr39860506+0.0029226590.99707735
ENST00000455057ENST00000426895IL17RCchr39974387+TTLL3chr39860506+0.0041335190.99586654
ENST00000455057ENST00000547186IL17RCchr39974387+TTLL3chr39860506+0.0026764530.9973236
ENST00000413608ENST00000426895IL17RCchr39974387+TTLL3chr39860506+0.0052676440.9947324
ENST00000413608ENST00000547186IL17RCchr39974387+TTLL3chr39860506+0.0034759140.99652404

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for IL17RC-TTLL3

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
IL17RCchr39974387TTLL3chr398605061440339LSLILLLKKDHAKEDFWLTAARNVLK
IL17RCchr39974387TTLL3chr398605061483494LSLILLLKKDHAKEDFWLTAARNVLK
IL17RCchr39974387TTLL3chr398605061540462LSLILLLKKDHAKEDFWLTAARNVLK
IL17RCchr39974387TTLL3chr398605061680479LSLILLLKKDHAKEDFWLTAARNVLK
IL17RCchr39974387TTLL3chr398605061680494LSLILLLKKDHAKEDFWLTAARNVLK
IL17RCchr39974387TTLL3chr398605061914565LSLILLLKKDHAKEDFWLTAARNVLK

Top

Potential FusionNeoAntigen Information of IL17RC-TTLL3 in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
IL17RC-TTLL3_9974387_9860506.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
IL17RC-TTLL3chr39974387chr398605061914HLA-B50:02KEDFWLTA0.99960.78011220
IL17RC-TTLL3chr39974387chr398605061914HLA-B41:01KEDFWLTA0.93710.95591220
IL17RC-TTLL3chr39974387chr398605061914HLA-B50:01KEDFWLTA0.89910.80151220
IL17RC-TTLL3chr39974387chr398605061914HLA-B45:01KEDFWLTAA0.99680.91611221
IL17RC-TTLL3chr39974387chr398605061914HLA-B50:02KEDFWLTAA0.99440.79281221
IL17RC-TTLL3chr39974387chr398605061914HLA-B39:01DHAKEDFWL0.99380.9153918
IL17RC-TTLL3chr39974387chr398605061914HLA-B38:02DHAKEDFWL0.98930.944918
IL17RC-TTLL3chr39974387chr398605061914HLA-B38:01DHAKEDFWL0.98830.952918
IL17RC-TTLL3chr39974387chr398605061914HLA-B15:37DHAKEDFWL0.94560.6604918
IL17RC-TTLL3chr39974387chr398605061914HLA-B41:01KEDFWLTAA0.45780.94931221
IL17RC-TTLL3chr39974387chr398605061914HLA-B50:01KEDFWLTAA0.41190.81591221
IL17RC-TTLL3chr39974387chr398605061914HLA-B39:06DHAKEDFWLTA0.99950.909920
IL17RC-TTLL3chr39974387chr398605061914HLA-B40:06KEDFWLTA0.99990.6751220
IL17RC-TTLL3chr39974387chr398605061914HLA-B40:06KEDFWLTAA0.99910.68411221
IL17RC-TTLL3chr39974387chr398605061914HLA-B39:09DHAKEDFWL0.99420.657918
IL17RC-TTLL3chr39974387chr398605061914HLA-B39:05DHAKEDFWL0.98880.8995918
IL17RC-TTLL3chr39974387chr398605061914HLA-B50:04KEDFWLTA0.89910.80151220
IL17RC-TTLL3chr39974387chr398605061914HLA-B50:05KEDFWLTA0.89910.80151220
IL17RC-TTLL3chr39974387chr398605061914HLA-B39:31DHAKEDFWL0.9940.9145918
IL17RC-TTLL3chr39974387chr398605061914HLA-B38:05DHAKEDFWL0.98830.952918
IL17RC-TTLL3chr39974387chr398605061914HLA-B15:09DHAKEDFWL0.91180.6637918
IL17RC-TTLL3chr39974387chr398605061914HLA-B39:11DHAKEDFWL0.73510.841918
IL17RC-TTLL3chr39974387chr398605061914HLA-B50:04KEDFWLTAA0.41190.81591221
IL17RC-TTLL3chr39974387chr398605061914HLA-B50:05KEDFWLTAA0.41190.81591221

Top

Potential FusionNeoAntigen Information of IL17RC-TTLL3 in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
IL17RC-TTLL3_9974387_9860506.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
IL17RC-TTLL3chr39974387chr398605061914DRB1-0103AKEDFWLTAARNVLK1126
IL17RC-TTLL3chr39974387chr398605061914DRB1-0109AKEDFWLTAARNVLK1126
IL17RC-TTLL3chr39974387chr398605061914DRB1-0113AKEDFWLTAARNVLK1126
IL17RC-TTLL3chr39974387chr398605061914DRB1-0115AKEDFWLTAARNVLK1126
IL17RC-TTLL3chr39974387chr398605061914DRB1-0117AKEDFWLTAARNVLK1126
IL17RC-TTLL3chr39974387chr398605061914DRB1-0121AKEDFWLTAARNVLK1126
IL17RC-TTLL3chr39974387chr398605061914DRB1-0701AKEDFWLTAARNVLK1126
IL17RC-TTLL3chr39974387chr398605061914DRB1-0701HAKEDFWLTAARNVL1025
IL17RC-TTLL3chr39974387chr398605061914DRB1-0701DHAKEDFWLTAARNV924
IL17RC-TTLL3chr39974387chr398605061914DRB1-0703AKEDFWLTAARNVLK1126
IL17RC-TTLL3chr39974387chr398605061914DRB1-0703HAKEDFWLTAARNVL1025
IL17RC-TTLL3chr39974387chr398605061914DRB1-0703DHAKEDFWLTAARNV924
IL17RC-TTLL3chr39974387chr398605061914DRB1-0704AKEDFWLTAARNVLK1126
IL17RC-TTLL3chr39974387chr398605061914DRB1-0704HAKEDFWLTAARNVL1025
IL17RC-TTLL3chr39974387chr398605061914DRB1-0704DHAKEDFWLTAARNV924
IL17RC-TTLL3chr39974387chr398605061914DRB1-0705AKEDFWLTAARNVLK1126
IL17RC-TTLL3chr39974387chr398605061914DRB1-0705HAKEDFWLTAARNVL1025
IL17RC-TTLL3chr39974387chr398605061914DRB1-0705DHAKEDFWLTAARNV924
IL17RC-TTLL3chr39974387chr398605061914DRB1-0706AKEDFWLTAARNVLK1126
IL17RC-TTLL3chr39974387chr398605061914DRB1-0706HAKEDFWLTAARNVL1025
IL17RC-TTLL3chr39974387chr398605061914DRB1-0706DHAKEDFWLTAARNV924
IL17RC-TTLL3chr39974387chr398605061914DRB1-0707AKEDFWLTAARNVLK1126
IL17RC-TTLL3chr39974387chr398605061914DRB1-0707HAKEDFWLTAARNVL1025
IL17RC-TTLL3chr39974387chr398605061914DRB1-0707DHAKEDFWLTAARNV924
IL17RC-TTLL3chr39974387chr398605061914DRB1-0708AKEDFWLTAARNVLK1126
IL17RC-TTLL3chr39974387chr398605061914DRB1-0708HAKEDFWLTAARNVL1025
IL17RC-TTLL3chr39974387chr398605061914DRB1-0708DHAKEDFWLTAARNV924
IL17RC-TTLL3chr39974387chr398605061914DRB1-0709AKEDFWLTAARNVLK1126
IL17RC-TTLL3chr39974387chr398605061914DRB1-0709HAKEDFWLTAARNVL1025
IL17RC-TTLL3chr39974387chr398605061914DRB1-0709DHAKEDFWLTAARNV924
IL17RC-TTLL3chr39974387chr398605061914DRB1-0711AKEDFWLTAARNVLK1126
IL17RC-TTLL3chr39974387chr398605061914DRB1-0711HAKEDFWLTAARNVL1025
IL17RC-TTLL3chr39974387chr398605061914DRB1-0711DHAKEDFWLTAARNV924
IL17RC-TTLL3chr39974387chr398605061914DRB1-0712AKEDFWLTAARNVLK1126
IL17RC-TTLL3chr39974387chr398605061914DRB1-0712HAKEDFWLTAARNVL1025
IL17RC-TTLL3chr39974387chr398605061914DRB1-0712DHAKEDFWLTAARNV924
IL17RC-TTLL3chr39974387chr398605061914DRB1-0713AKEDFWLTAARNVLK1126
IL17RC-TTLL3chr39974387chr398605061914DRB1-0713HAKEDFWLTAARNVL1025
IL17RC-TTLL3chr39974387chr398605061914DRB1-0713DHAKEDFWLTAARNV924
IL17RC-TTLL3chr39974387chr398605061914DRB1-0714AKEDFWLTAARNVLK1126
IL17RC-TTLL3chr39974387chr398605061914DRB1-0714HAKEDFWLTAARNVL1025
IL17RC-TTLL3chr39974387chr398605061914DRB1-0714DHAKEDFWLTAARNV924
IL17RC-TTLL3chr39974387chr398605061914DRB1-0715AKEDFWLTAARNVLK1126
IL17RC-TTLL3chr39974387chr398605061914DRB1-0715HAKEDFWLTAARNVL1025
IL17RC-TTLL3chr39974387chr398605061914DRB1-0715DHAKEDFWLTAARNV924
IL17RC-TTLL3chr39974387chr398605061914DRB1-0716AKEDFWLTAARNVLK1126
IL17RC-TTLL3chr39974387chr398605061914DRB1-0716HAKEDFWLTAARNVL1025
IL17RC-TTLL3chr39974387chr398605061914DRB1-0716DHAKEDFWLTAARNV924
IL17RC-TTLL3chr39974387chr398605061914DRB1-0717AKEDFWLTAARNVLK1126
IL17RC-TTLL3chr39974387chr398605061914DRB1-0717HAKEDFWLTAARNVL1025
IL17RC-TTLL3chr39974387chr398605061914DRB1-0717DHAKEDFWLTAARNV924
IL17RC-TTLL3chr39974387chr398605061914DRB1-0719AKEDFWLTAARNVLK1126
IL17RC-TTLL3chr39974387chr398605061914DRB1-0719HAKEDFWLTAARNVL1025
IL17RC-TTLL3chr39974387chr398605061914DRB1-0719DHAKEDFWLTAARNV924
IL17RC-TTLL3chr39974387chr398605061914DRB1-0804LSLILLLKKDHAKED015
IL17RC-TTLL3chr39974387chr398605061914DRB1-0806LSLILLLKKDHAKED015
IL17RC-TTLL3chr39974387chr398605061914DRB1-0807AKEDFWLTAARNVLK1126
IL17RC-TTLL3chr39974387chr398605061914DRB1-0819AKEDFWLTAARNVLK1126
IL17RC-TTLL3chr39974387chr398605061914DRB1-0820LSLILLLKKDHAKED015
IL17RC-TTLL3chr39974387chr398605061914DRB1-0822LSLILLLKKDHAKED015
IL17RC-TTLL3chr39974387chr398605061914DRB1-0824LSLILLLKKDHAKED015
IL17RC-TTLL3chr39974387chr398605061914DRB1-0825AKEDFWLTAARNVLK1126
IL17RC-TTLL3chr39974387chr398605061914DRB1-0828LSLILLLKKDHAKED015
IL17RC-TTLL3chr39974387chr398605061914DRB1-0828SLILLLKKDHAKEDF116
IL17RC-TTLL3chr39974387chr398605061914DRB1-0831LSLILLLKKDHAKED015
IL17RC-TTLL3chr39974387chr398605061914DRB1-0831SLILLLKKDHAKEDF116
IL17RC-TTLL3chr39974387chr398605061914DRB1-0834AKEDFWLTAARNVLK1126
IL17RC-TTLL3chr39974387chr398605061914DRB1-0901AKEDFWLTAARNVLK1126
IL17RC-TTLL3chr39974387chr398605061914DRB1-0902AKEDFWLTAARNVLK1126
IL17RC-TTLL3chr39974387chr398605061914DRB1-0903AKEDFWLTAARNVLK1126
IL17RC-TTLL3chr39974387chr398605061914DRB1-0904AKEDFWLTAARNVLK1126
IL17RC-TTLL3chr39974387chr398605061914DRB1-0904HAKEDFWLTAARNVL1025
IL17RC-TTLL3chr39974387chr398605061914DRB1-0905AKEDFWLTAARNVLK1126
IL17RC-TTLL3chr39974387chr398605061914DRB1-0905HAKEDFWLTAARNVL1025
IL17RC-TTLL3chr39974387chr398605061914DRB1-0907AKEDFWLTAARNVLK1126
IL17RC-TTLL3chr39974387chr398605061914DRB1-0907HAKEDFWLTAARNVL1025
IL17RC-TTLL3chr39974387chr398605061914DRB1-0908AKEDFWLTAARNVLK1126
IL17RC-TTLL3chr39974387chr398605061914DRB1-0909AKEDFWLTAARNVLK1126
IL17RC-TTLL3chr39974387chr398605061914DRB1-1104LSLILLLKKDHAKED015
IL17RC-TTLL3chr39974387chr398605061914DRB1-1104SLILLLKKDHAKEDF116
IL17RC-TTLL3chr39974387chr398605061914DRB1-1105LSLILLLKKDHAKED015
IL17RC-TTLL3chr39974387chr398605061914DRB1-1106LSLILLLKKDHAKED015
IL17RC-TTLL3chr39974387chr398605061914DRB1-1106SLILLLKKDHAKEDF116
IL17RC-TTLL3chr39974387chr398605061914DRB1-1113LSLILLLKKDHAKED015
IL17RC-TTLL3chr39974387chr398605061914DRB1-1118LSLILLLKKDHAKED015
IL17RC-TTLL3chr39974387chr398605061914DRB1-1125LSLILLLKKDHAKED015
IL17RC-TTLL3chr39974387chr398605061914DRB1-1134LSLILLLKKDHAKED015
IL17RC-TTLL3chr39974387chr398605061914DRB1-1134SLILLLKKDHAKEDF116
IL17RC-TTLL3chr39974387chr398605061914DRB1-1135LSLILLLKKDHAKED015
IL17RC-TTLL3chr39974387chr398605061914DRB1-1135SLILLLKKDHAKEDF116
IL17RC-TTLL3chr39974387chr398605061914DRB1-1138LSLILLLKKDHAKED015
IL17RC-TTLL3chr39974387chr398605061914DRB1-1138SLILLLKKDHAKEDF116
IL17RC-TTLL3chr39974387chr398605061914DRB1-1141LSLILLLKKDHAKED015
IL17RC-TTLL3chr39974387chr398605061914DRB1-1142LSLILLLKKDHAKED015
IL17RC-TTLL3chr39974387chr398605061914DRB1-1143LSLILLLKKDHAKED015
IL17RC-TTLL3chr39974387chr398605061914DRB1-1143SLILLLKKDHAKEDF116
IL17RC-TTLL3chr39974387chr398605061914DRB1-1144LSLILLLKKDHAKED015
IL17RC-TTLL3chr39974387chr398605061914DRB1-1144SLILLLKKDHAKEDF116
IL17RC-TTLL3chr39974387chr398605061914DRB1-1146LSLILLLKKDHAKED015
IL17RC-TTLL3chr39974387chr398605061914DRB1-1146SLILLLKKDHAKEDF116
IL17RC-TTLL3chr39974387chr398605061914DRB1-1147LSLILLLKKDHAKED015
IL17RC-TTLL3chr39974387chr398605061914DRB1-1147SLILLLKKDHAKEDF116
IL17RC-TTLL3chr39974387chr398605061914DRB1-1150LSLILLLKKDHAKED015
IL17RC-TTLL3chr39974387chr398605061914DRB1-1150SLILLLKKDHAKEDF116
IL17RC-TTLL3chr39974387chr398605061914DRB1-1154LSLILLLKKDHAKED015
IL17RC-TTLL3chr39974387chr398605061914DRB1-1156LSLILLLKKDHAKED015
IL17RC-TTLL3chr39974387chr398605061914DRB1-1156SLILLLKKDHAKEDF116
IL17RC-TTLL3chr39974387chr398605061914DRB1-1157LSLILLLKKDHAKED015
IL17RC-TTLL3chr39974387chr398605061914DRB1-1158LSLILLLKKDHAKED015
IL17RC-TTLL3chr39974387chr398605061914DRB1-1158SLILLLKKDHAKEDF116
IL17RC-TTLL3chr39974387chr398605061914DRB1-1159LSLILLLKKDHAKED015
IL17RC-TTLL3chr39974387chr398605061914DRB1-1160LSLILLLKKDHAKED015
IL17RC-TTLL3chr39974387chr398605061914DRB1-1160SLILLLKKDHAKEDF116
IL17RC-TTLL3chr39974387chr398605061914DRB1-1167LSLILLLKKDHAKED015
IL17RC-TTLL3chr39974387chr398605061914DRB1-1167SLILLLKKDHAKEDF116
IL17RC-TTLL3chr39974387chr398605061914DRB1-1172LSLILLLKKDHAKED015
IL17RC-TTLL3chr39974387chr398605061914DRB1-1172SLILLLKKDHAKEDF116
IL17RC-TTLL3chr39974387chr398605061914DRB1-1177LSLILLLKKDHAKED015
IL17RC-TTLL3chr39974387chr398605061914DRB1-1177SLILLLKKDHAKEDF116
IL17RC-TTLL3chr39974387chr398605061914DRB1-1178LSLILLLKKDHAKED015
IL17RC-TTLL3chr39974387chr398605061914DRB1-1178SLILLLKKDHAKEDF116
IL17RC-TTLL3chr39974387chr398605061914DRB1-1180LSLILLLKKDHAKED015
IL17RC-TTLL3chr39974387chr398605061914DRB1-1183LSLILLLKKDHAKED015
IL17RC-TTLL3chr39974387chr398605061914DRB1-1183SLILLLKKDHAKEDF116
IL17RC-TTLL3chr39974387chr398605061914DRB1-1184LSLILLLKKDHAKED015
IL17RC-TTLL3chr39974387chr398605061914DRB1-1184SLILLLKKDHAKEDF116
IL17RC-TTLL3chr39974387chr398605061914DRB1-1187LSLILLLKKDHAKED015
IL17RC-TTLL3chr39974387chr398605061914DRB1-1188LSLILLLKKDHAKED015
IL17RC-TTLL3chr39974387chr398605061914DRB1-1188SLILLLKKDHAKEDF116
IL17RC-TTLL3chr39974387chr398605061914DRB1-1192LSLILLLKKDHAKED015
IL17RC-TTLL3chr39974387chr398605061914DRB1-1192SLILLLKKDHAKEDF116
IL17RC-TTLL3chr39974387chr398605061914DRB1-1204LSLILLLKKDHAKED015
IL17RC-TTLL3chr39974387chr398605061914DRB1-1204SLILLLKKDHAKEDF116
IL17RC-TTLL3chr39974387chr398605061914DRB1-1209LSLILLLKKDHAKED015
IL17RC-TTLL3chr39974387chr398605061914DRB1-1209SLILLLKKDHAKEDF116
IL17RC-TTLL3chr39974387chr398605061914DRB1-1220LSLILLLKKDHAKED015
IL17RC-TTLL3chr39974387chr398605061914DRB1-1220SLILLLKKDHAKEDF116
IL17RC-TTLL3chr39974387chr398605061914DRB1-1306LSLILLLKKDHAKED015
IL17RC-TTLL3chr39974387chr398605061914DRB1-1309LSLILLLKKDHAKED015
IL17RC-TTLL3chr39974387chr398605061914DRB1-1311LSLILLLKKDHAKED015
IL17RC-TTLL3chr39974387chr398605061914DRB1-1311SLILLLKKDHAKEDF116
IL17RC-TTLL3chr39974387chr398605061914DRB1-1318LSLILLLKKDHAKED015
IL17RC-TTLL3chr39974387chr398605061914DRB1-1326LSLILLLKKDHAKED015
IL17RC-TTLL3chr39974387chr398605061914DRB1-1342LSLILLLKKDHAKED015
IL17RC-TTLL3chr39974387chr398605061914DRB1-1342SLILLLKKDHAKEDF116
IL17RC-TTLL3chr39974387chr398605061914DRB1-1344LSLILLLKKDHAKED015
IL17RC-TTLL3chr39974387chr398605061914DRB1-1344SLILLLKKDHAKEDF116
IL17RC-TTLL3chr39974387chr398605061914DRB1-1402LSLILLLKKDHAKED015
IL17RC-TTLL3chr39974387chr398605061914DRB1-1406LSLILLLKKDHAKED015
IL17RC-TTLL3chr39974387chr398605061914DRB1-1406SLILLLKKDHAKEDF116
IL17RC-TTLL3chr39974387chr398605061914DRB1-1407AKEDFWLTAARNVLK1126
IL17RC-TTLL3chr39974387chr398605061914DRB1-1412LSLILLLKKDHAKED015
IL17RC-TTLL3chr39974387chr398605061914DRB1-1412SLILLLKKDHAKEDF116
IL17RC-TTLL3chr39974387chr398605061914DRB1-1415LSLILLLKKDHAKED015
IL17RC-TTLL3chr39974387chr398605061914DRB1-1417LSLILLLKKDHAKED015
IL17RC-TTLL3chr39974387chr398605061914DRB1-1417SLILLLKKDHAKEDF116
IL17RC-TTLL3chr39974387chr398605061914DRB1-1420LSLILLLKKDHAKED015
IL17RC-TTLL3chr39974387chr398605061914DRB1-1420SLILLLKKDHAKEDF116
IL17RC-TTLL3chr39974387chr398605061914DRB1-1421LSLILLLKKDHAKED015
IL17RC-TTLL3chr39974387chr398605061914DRB1-1429LSLILLLKKDHAKED015
IL17RC-TTLL3chr39974387chr398605061914DRB1-1429SLILLLKKDHAKEDF116
IL17RC-TTLL3chr39974387chr398605061914DRB1-1431LSLILLLKKDHAKED015
IL17RC-TTLL3chr39974387chr398605061914DRB1-1434LSLILLLKKDHAKED015
IL17RC-TTLL3chr39974387chr398605061914DRB1-1434SLILLLKKDHAKEDF116
IL17RC-TTLL3chr39974387chr398605061914DRB1-1437LSLILLLKKDHAKED015
IL17RC-TTLL3chr39974387chr398605061914DRB1-1441LSLILLLKKDHAKED015
IL17RC-TTLL3chr39974387chr398605061914DRB1-1448AKEDFWLTAARNVLK1126
IL17RC-TTLL3chr39974387chr398605061914DRB1-1452LSLILLLKKDHAKED015
IL17RC-TTLL3chr39974387chr398605061914DRB1-1452SLILLLKKDHAKEDF116
IL17RC-TTLL3chr39974387chr398605061914DRB1-1468AKEDFWLTAARNVLK1126
IL17RC-TTLL3chr39974387chr398605061914DRB1-1478LSLILLLKKDHAKED015
IL17RC-TTLL3chr39974387chr398605061914DRB1-1480LSLILLLKKDHAKED015
IL17RC-TTLL3chr39974387chr398605061914DRB1-1480SLILLLKKDHAKEDF116
IL17RC-TTLL3chr39974387chr398605061914DRB1-1481LSLILLLKKDHAKED015
IL17RC-TTLL3chr39974387chr398605061914DRB1-1481SLILLLKKDHAKEDF116
IL17RC-TTLL3chr39974387chr398605061914DRB1-1483LSLILLLKKDHAKED015
IL17RC-TTLL3chr39974387chr398605061914DRB1-1483SLILLLKKDHAKEDF116
IL17RC-TTLL3chr39974387chr398605061914DRB1-1484LSLILLLKKDHAKED015
IL17RC-TTLL3chr39974387chr398605061914DRB1-1493AKEDFWLTAARNVLK1126
IL17RC-TTLL3chr39974387chr398605061914DRB1-1494LSLILLLKKDHAKED015
IL17RC-TTLL3chr39974387chr398605061914DRB1-1604AKEDFWLTAARNVLK1126
IL17RC-TTLL3chr39974387chr398605061914DRB5-0112AKEDFWLTAARNVLK1126

Top

Fusion breakpoint peptide structures of IL17RC-TTLL3

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
5158LKKDHAKEDFWLTAIL17RCTTLL3chr39974387chr398605061914

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of IL17RC-TTLL3

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN5158LKKDHAKEDFWLTA-6.73939-6.85279
HLA-B14:023BVN5158LKKDHAKEDFWLTA-5.8572-6.8925
HLA-B52:013W395158LKKDHAKEDFWLTA-6.06811-6.18151
HLA-B52:013W395158LKKDHAKEDFWLTA-4.01521-5.05051
HLA-A24:025HGA5158LKKDHAKEDFWLTA-6.11611-7.15141
HLA-A24:025HGA5158LKKDHAKEDFWLTA-5.72969-5.84309
HLA-B27:056PYJ5158LKKDHAKEDFWLTA-6.42433-7.45963
HLA-B44:053DX85158LKKDHAKEDFWLTA-5.79012-5.90352
HLA-B44:053DX85158LKKDHAKEDFWLTA-3.82099-4.85629

Top

Vaccine Design for the FusionNeoAntigens of IL17RC-TTLL3

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
IL17RC-TTLL3chr39974387chr398605061220KEDFWLTAAAGAGGACTTCTGGCTGACTGCTG
IL17RC-TTLL3chr39974387chr398605061221KEDFWLTAAAAGAGGACTTCTGGCTGACTGCTGCCC
IL17RC-TTLL3chr39974387chr39860506918DHAKEDFWLATCACGCGAAAGAGGACTTCTGGCTGA
IL17RC-TTLL3chr39974387chr39860506920DHAKEDFWLTAATCACGCGAAAGAGGACTTCTGGCTGACTGCTG

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
IL17RC-TTLL3chr39974387chr39860506015LSLILLLKKDHAKEDTTTCCCTCATCCTCCTTCTCAAAAAGGATCACGCGAAAGAGGACT
IL17RC-TTLL3chr39974387chr39860506116SLILLLKKDHAKEDFCCCTCATCCTCCTTCTCAAAAAGGATCACGCGAAAGAGGACTTCT
IL17RC-TTLL3chr39974387chr398605061025HAKEDFWLTAARNVLACGCGAAAGAGGACTTCTGGCTGACTGCTGCCCGCAACGTTCTCA
IL17RC-TTLL3chr39974387chr398605061126AKEDFWLTAARNVLKCGAAAGAGGACTTCTGGCTGACTGCTGCCCGCAACGTTCTCAAGC
IL17RC-TTLL3chr39974387chr39860506924DHAKEDFWLTAARNVATCACGCGAAAGAGGACTTCTGGCTGACTGCTGCCCGCAACGTTC

Top

Information of the samples that have these potential fusion neoantigens of IL17RC-TTLL3

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
LIHCIL17RC-TTLL3chr39974387ENST00000295981chr39860506ENST00000426895TCGA-GJ-A6C0-01A

Top

Potential target of CAR-T therapy development for IL17RC-TTLL3

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note
HgeneIL17RCchr3:9974387chr3:9860506ENST00000295981+1719539_559565792.0TransmembraneHelical

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to IL17RC-TTLL3

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to IL17RC-TTLL3

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource